United States · FDA National Drug Code directory
Pioglitazone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57237-219_f3308268-8023-434e-8caf-734ca298b98e
- Product NDC
- 57237-219
- Form
- TABLET
- Composition / generic term
- Pioglitazone
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130213
- Source listing expiry
- 20261231
Source-listed ingredients
- PIOGLITAZONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (57237-219-05) · 57237-219-05
- 30 TABLET in 1 BOTTLE (57237-219-30) · 57237-219-30
- 90 TABLET in 1 BOTTLE (57237-219-90) · 57237-219-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →